MedElevator
Войти в исследования Journal of medical genetics · 2026
Biallelic TTBK1 variant causes a severe syndromic neurodevelopmental disorder: clinical and genetic insights from two siblings.
СтатьяКлинический случайНазвание и аннотация: Перевод в очереди
Обработка статьи · этапы, ошибки и управление
Загрузка состояния…
Ошибки и ограничения
История · было → стало
Состояние обновляется каждые 5 секунд, пока блок открыт. Процент показывается только там, где известен объём работы. Пауза останавливает продолжение этапа; текущий запрос к источнику может завершиться.
Manav Yigit Zehra, Erarslan Salih Burak, Tosun Ayse, Bozkurt Gökay, Bolat Hilmi, Unsel Bolat Gul
Аннотация
BACKGROUND: Tau-tubulin kinase 1 (TTBK1) is a neuron-enriched kinase implicated in τ phosphorylation and neurodegeneration. Human phenotypes associated with constitutional TTBK1 variants remain undefined.
METHODS: Two siblings with a severe neurodevelopmental phenotype were assessed using quartet exome sequencing, segregation analysis and standardised clinical and neuroimaging evaluations.
RESULTS: Both children exhibited profound global developmental delay, non-ambulation, axial hypotonia with lower-limb spasticity and proportionate postnatal growth failure with microcephaly. Epilepsy was present in the older sibling. Brain MRI showed a thin brainstem and corpus callosum, periventricular T2 hyperintensities and mild cerebellar atrophy in the older sibling and external hydrocephalus in the younger. Exome sequencing identified a homozygous frameshift variant in TTBK1 (NM_032538.3:c.1899del; p.Thr634Argfs*39) that segregated with the disease. The variant was absent from population databases and predicted to cause loss-of-function. According to the American College of Medical Genetics and Genomics criteria, it fulfils PVS1 and PM2_P.
CONCLUSION: We report the two siblings with a neurodevelopmental disorder due to a biallelic TTBK1 loss-of-function variant, establishing TTBK1 as critical for human neurodevelopment. Together with preclinical data, these findings underscore its role in motor and cognitive circuits. Additional cases and functional studies will be essential to delineate the clinical spectrum and mechanistic basis of TTBK1 deficiency.
METHODS: Two siblings with a severe neurodevelopmental phenotype were assessed using quartet exome sequencing, segregation analysis and standardised clinical and neuroimaging evaluations.
RESULTS: Both children exhibited profound global developmental delay, non-ambulation, axial hypotonia with lower-limb spasticity and proportionate postnatal growth failure with microcephaly. Epilepsy was present in the older sibling. Brain MRI showed a thin brainstem and corpus callosum, periventricular T2 hyperintensities and mild cerebellar atrophy in the older sibling and external hydrocephalus in the younger. Exome sequencing identified a homozygous frameshift variant in TTBK1 (NM_032538.3:c.1899del; p.Thr634Argfs*39) that segregated with the disease. The variant was absent from population databases and predicted to cause loss-of-function. According to the American College of Medical Genetics and Genomics criteria, it fulfils PVS1 and PM2_P.
CONCLUSION: We report the two siblings with a neurodevelopmental disorder due to a biallelic TTBK1 loss-of-function variant, establishing TTBK1 as critical for human neurodevelopment. Together with preclinical data, these findings underscore its role in motor and cognitive circuits. Additional cases and functional studies will be essential to delineate the clinical spectrum and mechanistic basis of TTBK1 deficiency.